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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A405molecules to circulation in order to maintain the high-viscosity needed
for efﬁcient lubrication by synovial ﬂuid. One example of this challenge
is that most contrast-enhanced clinical imaging protocols deﬁne carti-
lage defects by exclusion of systemically delivered small molecule
contrast agents. This architecture presents a challenge to effective drug
delivery for treating OA. We hypothesized that cationic TAT-PTDs
(Peptide Transduction Domains) would enable in vivo drug delivery
into synovial joints because of electrostatic attraction between the
cationic TAT PTD and anionic cartilage glycosaminoglycans.
Methods: To address our hypothesis, we utilized a non-invasive in
vivo model of post-traumatic OA. In this model, joints are subjected
to a single mechanical overload which results in upregulation of IL-6
mRNA. 24 hours prior to injury, we treated the animals with siRNA
complexed to a TAT-PTD fusion protein for delivery of siRNA. The
fusion protein, TAT PTD-DRBD (Protein Transduction Domain cou-
pled to a Double-stranded RNA Binding Domain), was complexed to
siRNA at a 1:8 molar ratio of siRNA to protein. Controls included
both untreated and off-target-treated joints. Therapeutic com-
pounds and controls were delivered via 12 mL injection to the
selected knee joint using a medial approach. Joints were injured by a
single mechanical overload applied at 500 mm/s which results in a
mid-substance tear of the ACL. Joints were harvested for qPCR 1
week after injury.
Results: Injury resulted in upregulation of IL-6 mRNA in the injured
knee joint relative to the uninjured contralateral knee. There was
signiﬁcantly less upregulation of IL-6 mRNA in injured joints treated
with the PTD-DRBD complexed to an anti-IL-6 siRNA (p ¼ 0.027,
Figure 1) while treatment treated with off-target siRNA complexes had
no effect.
Conclusions: These data demonstrate the feasibility of in vivo bioactive
drug delivery to synovial joints using the TAT Peptide Transduction
Domain, in this example for delivery of siRNA to attenuate injury-
induced expression of IL-6. Future studies may utilize TAT fusion pro-
teins as well as the PTD-DRBD to advance both basic and translational
studies of osteoarthritis.
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INTRA-ARTICULAR AUGMENTATION OF LUBRICATION WITH SILK
MICROSPHERES
X. Wang, J. Guo, A. Tweed-Kent, A. Dovletoglou, D. Kaplan, A. Bellinger.
Cocoon Biotech, Boston, MA, USA
Purpose: Osteoarthritis of the knee represents a large unmet clinical
need. Deﬁcits in synovial lubrication have been reported in osteo-
arthritis, and several strategies to augment lubrication have shown
preclinical beneﬁt. We hypothesized that augmentation of the boun-
dary lubrication of synovial ﬂuid by intra-articular administration of
long-residence non-inﬂammatory lubricating silk microspheres could
reduce mechanical injury and pain in an osteoarthritis animal model.Methods: Silk microspheres with phospholipid coatings were prepared
by a modiﬁed version of previously published methods. Osteoarthritis
was induced in rats using the surgical instability model consisting of
MCL tear and meniscectomy. One week following injury, affected knees
were intra-articularly administered saline vehicle or silk microspheres
(2.5mg). Serial body weights, knee effusion, gait analysis on Day 14, and
Von Frey secondary allodynia testing on Days -1, 6, and 13 were
measured. Severity of osteoarthritis was assessed by histopathologic
analysis by a trained pathologist on Day 28 after injury.
Results: Silk microspheres with varying size distributions were syn-
thesized and achieved coefﬁcients of friction approaching 0.05 to 0.02.
Intra-articular injection of silk microspheres was well tolerated in rats
with no adverse reactions. Von Frey testing of secondary allodynia 6
days after injection indicated a trend towards a modest but sustained
reduction of osteoarthritic pain.
Conclusions: Intra-articular silk microspheres offer a novel, biologically
inert, non-inﬂammatory, and well tolerated potential therapy for
osteoarthritis. These results motivate further formulation optimization
of silkmicrosphere composition to tune synovial residence, degradation
proﬁle, lubrication properties, and potentially to provide prolonged
delivery of active therapeutics. Augmentation of joint lubrication with
silk microspheres merits further preclinical exploration as a novel
therapy to address the unmet need in osteoarthritis.
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BMI, AGE, RADIOGRAPHIC SEVERITY AND ULTRASOUND GUIDANCE
IMPACT THE RESPONSE TO HYALURONIC ACID INJECTIONS IN KNEE
OSTEOARTHRITIS
E. Wilder, R. Flanagan, E. Strauss, J. Samuels. NYU Langone Hosp. for Joint
Diseases, New York, NY, USA
Purpose:While hyaluronic acid (HA) viscosupplementation has shown
promise in the management of patients with knee osteoarthritis (KOA),
mixed outcome data has led both individual physicians and subspeci-
alty societies to question or eliminate its role in treatment algorithms.
We examined clinical predictors of response to HA injections in a pro-
spective study.
Methods: We screened consecutive patients at HA injections during
routine clinical visits to rheumatology, orthopedics or physiatry at NYU
Langone Medical Center, enrolling those 25 years old with KOA and
pain for 1 month and a visual analog scale pain score 30mm. Base-
line assessments included OA severity by the Kellgren-Lawrence (KL)
scale on knee radiographs within the year prior, a history of comor-
bidities and prior KOA treatment, and patient-reported questionnaires
including the Knee Injury and Osteoarthritis Outcome Score (KOOS),
and the Western Ontario McMasters Universities Osteoarthritis Index
(WOMAC) with a Likert scale calculated from the KOOS. We docu-
mented other variables such as the speciﬁc HA formulation, the ana-
tomic approach, and use of ultrasound guidance. Patients are
completing the questionnaires at 2, 6, 9 and 12 month intervals, but
only continue past 2 months as long as there was still some beneﬁt at
the preceding visit.
Results: Thus far we have screened 194 patients with (ongoing)
enrollment now at 107 (61% female, mean age 58 years ±11, range 27-
84). To date, the cohort’s mean BMI is 30.9 kg/m2±6.6, range 20.9-61.7,
well distributed by BMI subgroup (&lt25, 25-30¼overweight, 30-
35¼obese, and &gt35¼morbidly obese). At baseline, the mean KOOS
pain score (0¼worst, 100¼best) is 47.1 ±17.4, range 0-83.3, and the
WOMAC index (0¼best, 96¼worst) is 45.1±17.8, range 12-96, without a
signiﬁcant difference between the 4 BMI strata. X-rays have been scored
on 85 patients thus far (others are obtaining recent images from other
institutions), but neither the KOOS pain nor WOMAC index at baseline
trends with x-ray severity. Of 102 patients (5 withdrew), 38 have
completed their 2 month followup visits. Patients with a BMI&lt30
(n¼23) responded better than &gt30 (n¼15), both by KOOS pain (þ17.1
vsþ9.2, p¼0.09) andWOMAC index (-15.7 vs -9.2, p¼0.14), with similar
trends across other KOOS and WOMAC scores. The KOOS pain
improvements were better for radiographic grades KL2 and KL3 than
those seen for KL4 (þ 12.8 and þ15.1 vs þ5.9, p¼0.13 for KL 3vs4), as
were the WOMAC index scores (-19.3, -13.7 vs -6.5) The youngest
quartile (ages 37-54) responded better than the middle 2 and the oldest
quartile (ages 70-84) by KOOS pain (þ18.2, þ17.6, þ12.3, þ7.1, p¼0.04
Table 1
Baseline characteristics HTO versus KJD
Characteristics Mean (± SEM) HTO (n ¼ 45) KJD(n ¼ 22)
Male gender (n) 27/45 (60%) 16/22 (73%)
Height (cm) 177 ± 2 178 ± 2
Weight (kg) 85.2 ± 2.1 87.2 ± 2.8
Body mass index (kg/m2) 27.2 ± 0.5 27.5 ± 0.7
Affected knee (left) 20/45 (44%) 10/22 (45%)
Most affected compartment (medial) 45/45 22/22
Age at surgery (yr) 49.4 ± 1.0 51.2 ± 1.1
Kellgren & Lawrence grade 2.5 ± 0.1 2.3 ± 0.2
Grade 0 (n) 1 0
Grade 1 (n) 5 6
Grade 2 (n) 12 4
Grade 3 (n) 23 11
Grade 4 (n) 4 1
Tibiofemoral axis () 6.2 ± 0.3 5.8 ± 0.6
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A406for quartiles 1 vs 4), and by WOMAC index (-17.9, -15.7, -13.1, -5.6,
p¼0.03 for 1 vs 4), despite similar baseline pain scores for each quartile.
The multi-week formulations (n¼27) of HA provided more relief than
the single-injection products (n¼11), with improvements of þ15.7 vs
þ9.9, p¼0.26 by KOOS pain and -15.4 vs -7.6, p¼0.11 by WOMAC index.
The use of ultrasound guidance associated strongly with better relief, by
KOOS pain (þ19.0 vs þ9.1, p¼0.05) and the WOMAC index (-19 vs -7.3,
p¼ 0.01) Gender, anatomic injection technique (medial, lateral, anterior
ﬂexed) and prior HA injections had no effect on symptoms.
Conclusions: In our preliminary data thus far, patients reporting more
relief 2 months after HA injection were younger and had lower BMIs
and less severe radiographic arthritis, while the use of ultrasound
guidance and selection of drug administered over multiple weeks also
associated with improved outcomes. These data, with further enroll-
ment and longer followup, could help tailor future algorithms for more
appropriate, successful, and cost-effective use of HA viscosupple-
mentation in the non-operative management of KOA.
Therapy: Surgery
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KNEE JOINT DISTRACTION COMPARED WITH HIGH TIBIAL
OSTEOTOMY: A RANDOMIZED CONTROLLED TRIAL.
J.A. van der Woude y, R.J. van Heerwaarden z, S. Spruijt z, K. Wiegant y,
P.M. van Roermund y, D.B. Saris y, S.C. Mastbergen y, F.P. Lafeber y. yUniv.
Med. Ctr. Utrecht, Utrecht, Netherlands; z Sint Maartenskliniek, Woerden,Table 2
pre- and postoperative follow-up data for both treatments
Score HTO BL HTO 3m HTO 6m HTO 12m HTO BL ->1y KJD BL KJD 3m KJD 6m KJD 12m KJD BL ->1y
WOMAC Pain 49±18 68±17* 76±19* 81±18* 32±18# 55±17 69±23* 76±20* 76±15* 21±19
Stiffness 47±20 58±21* 64±23* 69±19* 22±21# 52±20 56±21 58±19 60±18 8±25
Function 54±17 68±14* 76±18* 82±17* 28±18 58±19 65±22 75±19* 78±19* 21±17
Total 52±16 67±14* 75±17* 81±16* 28±17 57±18 65±20 74±18* 76±17* 20±16
VAS (0-100) Pain 65±18 47±26* 37±24* 27±23* -38±24# 54±23 46±29 34±23* 36±26* -18±26
EQ-5D (0-1) Index score 0.64±0.2 0.68±0.2# 0.68±0.3 0.79±0.3* 0.15±0.3 0.63±0.2 0.52±0.3 0.69±0.2 0.77±0.1* 0.14±0.3
X-ray Mean 1.96±1 2.44±1* 0.48±1 2.01±1 2.78±1* 0.77±1
(JSW) Min 0.60±1 0.96±1* 0.37±1 0.51±1 1.33±1* 0.82±1Netherlands
Purpose: Knee joint distraction (KJD) results in clinical improvement
and cartilage repair in young, active patients with knee OA. Another
knee preserving treatment, in medial compartment knee osteo-
arthritis, is a high tibial osteotomy (HTO), which has good mid-term
and longer follow-up results. However, no comparative data on efﬁ-
cacy is available. A RCT was set out and determined whether there was
a clinical relevant difference in functional outcome after 1-year
between KJD and HTO.
Methods: 69 patients with medial osteoarthritis were included and
randomized to KJD (23 patients) or HTO (46 patients). A WOMAC
questionnaire (100 being the best) was assessed at baseline (BL) and 12
months. EQ-5D index score was used to assess improvement in the
quality of life (1 being the best). Joint space width (JSW) of the medial
compartment was determined on standardized semi-ﬂexed x-rays at BL
and 1-year. For the tables: A asterisk indicates P < 0.05 relative to the
preoperative baseline score, a hashtag indicates P< 0.05 relative to the
other treatment group (KJD).
Results: Of the 69 patients enrolled in the randomized controlled
trial, 23 were assigned to KJD and 46 to HTO. After randomization one
patient who was assigned KJD and one patient who was assigned HTO
were excluded. Of the remaining 67 patients the baseline character-
istics of the affected knee is given in table 1. Total WOMAC scores
demonstrated signiﬁcant clinical improvement in both groups. The
KJD group increased from 57±17 points at BL to 76±17 points at 1-
year (p<0.001). Similarly, the HTO group had a score of 52±16 points
at BL, which increased to 81±16 points (p<0.001). Parallel results
were seen for the VAS and the quality of life (table 2). None of the
parameters showed a statistical signiﬁcant difference between the
two groups at 1-year (p¼0.318, p¼0.170 and p¼0.787 resp.). Both the
minimum and mean JSW showed a steeper increase in the KJD-group
(table 2).Conclusions: Six weeks of KJD does not lead to a clinical relevant dif-
ference in outcome compared with HTO after 1-year. Importantly both
KJD and HTO lead to substantial newly formed cartilage-like tissue with
superiority of KJD. Thus KJD is an alternative option in patients less
suitable for HTO.681
PREOPERATIVE DETERMINANTS OF EARLY AND MEDIUM TERM
PATIENT-REPORTED PAIN AND DISABILITY FOLLOWING TOTAL
KNEE ARTHROPLASTY: A SYSTEMATIC REVIEW
E. Lungu, P.-A. Vendittoli, F. Desmeules. Maisonneuve-Rosemont Hosp.,
Montreal, QC, Canada
Purpose: Total knee arthroplasty (TKA) is a common procedure inten-
ded at treating patients with advanced knee osteoarthritis (OA).
Although TKA is generally a successful intervention, leading to a dra-
matic amelioration in pain levels as well as functioning status, it yields
unsatisfactory results in up to one third of patients. A sound knowledge
of the determinants of TKA outcomes can help in patient selection,
preparation and education, especially regarding possible risks and
beneﬁts of the procedure. Currently, the published systematic reviews
summarizing the evidence of preoperative determinants base their
ﬁndings on studies with low methodological quality and focus on par-
ticular types of determinants. Therefore, no consensus exists regarding
either the identity or the strength of the association of TKA determi-
nants with poor outcomes. The purpose of this systematic review was
therefore to assess the current status of the literature evaluating pre-
operative determinants of early and medium term patient-reported
pain and disability.
Methods: A search in four databases (Medline, Pubmed, Embase and
CINAHL) from their respective inception dates until October 2014 was
undertaken using a combination of keywords and MESH terms. Two
authors independently reviewed the titles, abstracts and full texts of the
articles in order to evaluate their eligibility. Selection criteria included:
1- participants undergoing primary unilateral TKA with a follow-up up
to 2 years, 2- validated disease-speciﬁc patient-reported outcome
measures assessing pain and/or function used as outcome measure and
3- identiﬁcation of preoperative determinants obtained via multivariate
analyses. The risk of bias and the methodological quality of the included
